Join us on Saturday, January 23rd, 2021, at 12:00 pm EST for a webinar featuring a discussion of how gene therapies can be used to address retinal degenerative diseases, as well as the latest updates on gene therapy research and clinical trials.
The Free Family Age-Related Macular Degeneration (AMD) Award funding strives to find solutions for early, dry AMD. Efforts are concentrated on determining the strength of pathophysiologic pathways and their interactions with other pathways to cause AMD lesions of early AMD pathobiology. This award will include two PIs who are jointly responsible for the scientific and technical direction of the project, thereby leveraging a team science approach. Multidisciplinary projects are highly encouraged.
All prospective award recipients first submit a Letter of Intent and, by invitation only, an application via the Foundation’s online application portal. Application guidelines should be downloaded and reviewed before beginning your letter or application.
The urgent mission of the Foundation Fighting Blindness is to drive the research that will provide preventions, treatments and cures for people affected by retinitis pigmentosa, macular degeneration, Usher syndrome and the entire spectrum of retinal degenerative diseases. The Foundation is a beacon for those affected by these blinding diseases. Join the fight and help us accelerate our mission.
Welcome to the Foundation site — supported in partnership with Genentech, A Member of the Roche Group.